• Twitter
  • Jobs
ProCURE oncology
  • HOME
  • ABOUT US
  • RESEARCH GROUP
    • Molleví’s Lab
    • Antolin’s Lab
    • Alemany’s & Piulats’s lab
    • Martínez-Balibrea’s Lab
    • Aytes’s Lab
    • Belver’s Lab
    • Pujana’s Lab
    • Menendez’s Lab
    • Sureda’s & Farre’s Lab
    • Casanovas’s Lab
    • Viñals’s lab
  • INNOVATION
  • NEWS
  • CONTACT
  • Menu Menu

News

Transparente Casino-Reviews bei Alf Casino für informierte Entscheidungen

9 de August de 2026
Casino-Reviews richtig lesen, bevor eine Entscheidung fällt Was…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 Susana https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg Susana2026-08-09 12:17:092026-08-09 12:17:09Transparente Casino-Reviews bei Alf Casino für informierte Entscheidungen

Oncolytic adenovirus incorporating TetO sites in the E1A promoter for controlled replication in TetR-expressing mesenchymal stem cells

7 de August de 2026
Mol Ther Oncol. 2026 Jul 10;34(3):201291. doi: 10.1016/j.omton.2026.201291.…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 Susana https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg Susana2026-08-07 10:00:002026-08-07 10:00:00Oncolytic adenovirus incorporating TetO sites in the E1A promoter for controlled replication in TetR-expressing mesenchymal stem cells

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial

6 de August de 2026
Lancet. 2026 Aug 6:S0140-6736(26)01092-5. doi: 10.1016/S0140-6736(26)01092-5.…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 Susana https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg Susana2026-08-06 10:00:002026-08-06 10:00:00[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial

Haematopoietic cell transplantation for relapsed or refractory classical Hodgkin lymphoma: a retrospective, registry-based cohort study of 19 498 patients from the EBMT Lymphoma Working Group

30 de July de 2026
Lancet Haematol. 2026 Aug;13(8):e519-e532. doi: 10.1016/S2352-3026(26)00169-9.ABSTRACTBACKGROUND:…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 Susana https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg Susana2026-07-30 10:00:002026-07-30 10:00:00Haematopoietic cell transplantation for relapsed or refractory classical Hodgkin lymphoma: a retrospective, registry-based cohort study of 19 498 patients from the EBMT Lymphoma Working Group

Baxterbet Casino – ehrliche Casino-Reviews mit Details zu Service

27 de July de 2026
Baxterbet Casino, ehrliche Casino-Reviews mit Blick auf den…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 Susana https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg Susana2026-07-27 12:17:082026-07-27 12:17:08Baxterbet Casino – ehrliche Casino-Reviews mit Details zu Service

Autologous stem cell transplantation in POEMS syndrome: Multicenter real-world treatment patterns and outcomes

25 de July de 2026
Bone Marrow Transplant. 2026 Jul 25. doi: 10.1038/s41409-026-02984-0.…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 Susana https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg Susana2026-07-25 10:00:002026-07-25 10:00:00Autologous stem cell transplantation in POEMS syndrome: Multicenter real-world treatment patterns and outcomes

MRD dynamics predicts progression and reveals a vulnerable state for immunotherapy interception in multiple myeloma

24 de July de 2026
Blood. 2026 Jul 24:blood.2026033878. doi: 10.1182/blood.2026033878.…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 Susana https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg Susana2026-07-24 10:00:002026-07-24 10:00:00MRD dynamics predicts progression and reveals a vulnerable state for immunotherapy interception in multiple myeloma

Eltrombopag Added to Standard Immunosuppressive Treatment as Front-Line Therapy for Severe Aplastic Anemia: Long-Term Outcomes of the Phase-3 Randomized Superiority EBMT-SAAWP RACE Study

19 de July de 2026
Am J Hematol. 2026 Jul 19. doi: 10.1002/ajh.70445. Online ahead…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 Susana https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg Susana2026-07-19 10:00:002026-07-19 10:00:00Eltrombopag Added to Standard Immunosuppressive Treatment as Front-Line Therapy for Severe Aplastic Anemia: Long-Term Outcomes of the Phase-3 Randomized Superiority EBMT-SAAWP RACE Study

Zahlungsmittel im Casino sicher einsetzen und Konten verwalten

17 de July de 2026
Zahlungsmittel im Casino sicher einsetzen und Konten verwalten Warum…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 Susana https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg Susana2026-07-17 12:17:092026-07-17 12:17:09Zahlungsmittel im Casino sicher einsetzen und Konten verwalten

Rabona Casino – partidas de crash diseñadas para acción rápida y sencilla

16 de July de 2026
Rabona Casino y las partidas de crash de ritmo inmediato Cómo…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 Susana https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg Susana2026-07-16 12:17:082026-07-16 12:17:08Rabona Casino – partidas de crash diseñadas para acción rápida y sencilla

Erratum for Laporte-Amargos et al., “Population pharmacokinetics and optimized dosing of piperacillin-tazobactam in hematological patients with febrile neutropenia”

15 de July de 2026
Antimicrob Agents Chemother. 2026 Jul 15:e0074026. doi: 10.1128/aac.00740-26.…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 Susana https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg Susana2026-07-15 10:00:002026-07-15 10:00:00Erratum for Laporte-Amargos et al., “Population pharmacokinetics and optimized dosing of piperacillin-tazobactam in hematological patients with febrile neutropenia”

Aneuploidy selects for the acquisition of driver genes in breast cancer

8 de July de 2026
Nature. 2026 Jul 8. doi: 10.1038/s41586-026-10752-9. Online ahead…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 Susana https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg Susana2026-07-08 10:00:002026-07-08 10:00:00Aneuploidy selects for the acquisition of driver genes in breast cancer
Page 2 of 87‹1234›»

Filter by categories

  • Alemany’s & Piulats’s lab (133)
  • Antolin's lab (36)
  • Aytes's Lab (25)
  • Belver's Lab (25)
  • Casanovas's Lab (77)
  • Martínez-Balibrea's Lab (43)
  • Menendez's Lab (121)
  • Molleví's Lab (35)
  • Pujana's Lab (110)
  • Sin categoría (5)
  • Sureda's & Farre's Lab (312)
  • Viñals's lab (111)

Twitter

Tweets by ProcureICO
Program Against Cancer Therapeutic Resistance

CONTACT US

Campus IDIBELL
(L’Hospitalet del Llobregat)
Hospital Duran i Reynals, Gran Via 199,
L’Hospitalet del Llobregat,
Barcelona 08908
Tel. +34 93 260 7952

Campus IGTP-IJC
(Badalona)
Campus Can Ruti – IGTP – Building Muntanya,
Rd. Can Ruti, Camí de les escoles s/n,
Badalona, Barcelona 08916
Tel. +34 93 554 3069

Campus IDIBGI
(Girona)
Parc Hospitalari Martí i Julià de Salt, Dr. Castany s/n,
Salt, Girona 17190
Tel. +34 872 987 087

© Copyright - Edisenius
  • Privacy Policy
  • Cookie Policy
  • Legal Notice
Scroll to top
Manage cookie consent
To offer the best experiences, we use technologies such as cookies to store and/or access device information. Consent to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Failure to consent, or withdrawal of consent, may adversely affect certain features and functions.
Functional Always active
Storage or technical access is strictly necessary for the legitimate purpose of allowing the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. Storage or technical access that is used exclusively for anonymous statistical purposes. Without a requirement, voluntary compliance by your Internet service provider, or additional records from a third party, information stored or retrieved solely for this purpose cannot be used to identify you.
Marketing
Storage or technical access is necessary to create user profiles to send advertising, or to track the user on a website or several websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
See preferences
{title} {title} {title}